GLP-1 Drugs Out-Earned OpenAI and Anthropic Combined: $71B vs $29B
vaibhavbetter · x · 2026-09-08
Mansi Hukmani offers a striking comparison: Ozempic and Mounjaro generated $71B in 2025 — over 2x the combined $29B revenue of OpenAI and Anthropic.
Her thesis: products touching deeply rooted human motives win, regardless of policy or regulation — consumers find a way when desire is deep enough, with human health as the ultimate example. The reposter adds that AI-accelerated bio innovation will amplify this trend.
More from AGI Musings
- Agents Now Automate Dirty, High-Leverage Grunt Work, and Veterans Benefit Most — HanchungLee · 2026-09-08
- Distilling Isn't Just for Models: Any Observable Software Can Be Copied Exactly — cephaloform · 2026-09-08
- 'Profecía': New Book Argues Every Prediction Model Hides a Moral Judgment — CarissaVeliz · 2026-09-08
- 'Building apps is over'? Shredded Cheese growth says most people still won't build — heyneighbor · 2026-09-08
- Economist analysis: AI has created ~1 million new jobs in the US so far — markjeffrey · 2026-09-08
- Apollo Research CEO: 2026 looks like a sad year for AGI safety so far — kalladomcdowell · 2026-09-08